Erudio Healtherudio.com
Drug
177Lu-girentuximab trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying 177Lu-girentuximab: STARLITE-2. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| STARLITE-2 NCT05239533 · Memorial Sloan Kettering Cancer Center | advanced clear cell renal cell carcinoma | Phase 2 | 2 | 3 | Focused | Nov 21, 2026 | Preview |